Family Medicine · Oklahoma City, OK
NPI
1649929738
Since 2022
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9417 N Council Rd Ste 200
Oklahoma City, OK, 73162
Phone (405) 470-2590
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$86K
723 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gailynn Sybrandy prescribed most often to Medicare patients was Amlodipine Besylate, with 51 prescriptions and refills. In total Gailynn Sybrandy wrote 723 Medicare prescriptions that cost $86K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Amlodipine Besylate Generic | 51 | 123 | 18 | $357 |
| Atorvastatin Calcium Generic | 46 | 130 | 19 | $372 |
| Omeprazole Generic | 22 | 32 | Under 11 | $346 |
| Carvedilol Generic | 21 | 45 | Under 11 | $164 |
| Metformin Hcl Generic | 20 | 48 | Under 11 | $144 |
| Jardiance Empagliflozin | 18 | 26 | Under 11 | $16K |
| Lisinopril Generic | 17 | 44 | Under 11 | $119 |
| Losartan Potassium Generic | 17 | 38 | Under 11 | $232 |
| Metformin Hcl Er Metformin Hcl | 17 | 31 | Under 11 | $81.41 |
| Montelukast Sodium Generic | 15 | 29 | Under 11 | $203 |
| Metoprolol Succinate Generic | 15 | 17 | Under 11 | $138 |
| Fluticasone Propionate Generic | 14 | 34 | Under 11 | $221 |
| Levothyroxine Sodium Generic | 14 | 42 | Under 11 | $270 |
| Trulicity Dulaglutide | 14 | 16 | Under 11 | $16K |
| Aripiprazole Generic | 14 | 14 | Under 11 | $95.59 |
Brand drugs: - claims; generic drugs: 604 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gailynn Sybrandy were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.